Pacific University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Pacific University sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 1 currently recruiting 8 completed top decile by trial count

Pacific University: 11 sponsored US clinical trials, 1 recruiting.

Pacific University sponsors 11 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. The most-studied condition in this pipeline is Recidivism, with 1 trials.

Top-decile sponsor footprint

Pacific University ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

What is open in the Pacific University pipeline

1 recruiting of 11 indexed (9% open); 8 completed (73%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Recidivism (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Pacific University: open-pipeline peers nationwide

Peers matched on 11 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Pacific University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080 0%2%4%6%8%10% Total trials Recruiting share Pacific UniversityAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeAlkermesDBV TechnologiesFlorida Gulf Coast UniversityGenfit
Pacific University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Pacific University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

What to do with this Pacific University page

11 registered trials is a research-attention snapshot, not an endorsement of Pacific University or any single study.

  • 1 of Pacific University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Recidivism is the condition Pacific University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Recidivism trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Pacific University pipeline card: 11 registered trials from official public datasets.Report a data error.